{"id":1851,"date":"2013-06-07T12:25:47","date_gmt":"2013-06-07T11:25:47","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=1851"},"modified":"2013-06-07T12:25:47","modified_gmt":"2013-06-07T11:25:47","slug":"latencio-dermofarmaceutica-en-psoriasi","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/","title":{"rendered":"L\u2019atenci\u00f3 dermofarmac\u00e8utica en Psoriasi"},"content":{"rendered":"\n<p>Tenir una visi\u00f3 integral de la psoriasi incidint en la dermocosm\u00e8tica i els nous productes sanitaris espec\u00edfics per millorar l\u2019estat de la pell, la simptomatologia, la dosi de medicaci\u00f3 i aportar una millor qualitat de vida als pacients afectats. Aquest va ser l\u2019objectiu de la confer\u00e8ncia que el Col\u00b7legi va organitzar el 14 de maig, amb el patrocini dels Laboratoris La Roche-Posay.<\/p>\n<p>La confer\u00e8ncia a c\u00e0rrec de <b>Leonor Prieto<\/b>, farmac\u00e8utica i directora cient\u00edfica i de formaci\u00f3 de Laboratoris La Roche-Posay, va ser moderada per <b>N\u00faria Bosch<\/b>, vocal de Dermofarm\u00e0cia i Productes sanitaris del COFB.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tenir una visi\u00f3 integral de la psoriasi incidint en la dermocosm\u00e8tica i els nous productes sanitaris espec\u00edfics per millorar l\u2019estat de la pell, la simptomatologia, la dosi de medicaci\u00f3 i aportar una millor qualitat de vida als pacients afectats. Aquest va ser l\u2019objectiu de la confer\u00e8ncia que el Col\u00b7legi va [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1852,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[64,70],"class_list":["post-1851","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-atencio-farmaceutica","tag-formacio"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L\u2019atenci\u00f3 dermofarmac\u00e8utica en Psoriasi - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019atenci\u00f3 dermofarmac\u00e8utica en Psoriasi - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Tenir una visi\u00f3 integral de la psoriasi incidint en la dermocosm\u00e8tica i els nous productes sanitaris espec\u00edfics per millorar l\u2019estat de la pell, la simptomatologia, la dosi de medicaci\u00f3 i aportar una millor qualitat de vida als pacients afectats. Aquest va ser l\u2019objectiu de la confer\u00e8ncia que el Col\u00b7legi va [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-06-07T11:25:47+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"L\u2019atenci\u00f3 dermofarmac\u00e8utica en Psoriasi\",\"datePublished\":\"2013-06-07T11:25:47+00:00\",\"dateModified\":\"2013-06-07T11:25:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/\"},\"wordCount\":115,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 farmac\u00e8utica\",\"Formaci\u00f3\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/\",\"name\":\"L\u2019atenci\u00f3 dermofarmac\u00e8utica en Psoriasi - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2013-06-07T11:25:47+00:00\",\"dateModified\":\"2013-06-07T11:25:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u2019atenci\u00f3 dermofarmac\u00e8utica en Psoriasi\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019atenci\u00f3 dermofarmac\u00e8utica en Psoriasi - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/","og_locale":"ca_ES","og_type":"article","og_title":"L\u2019atenci\u00f3 dermofarmac\u00e8utica en Psoriasi - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Tenir una visi\u00f3 integral de la psoriasi incidint en la dermocosm\u00e8tica i els nous productes sanitaris espec\u00edfics per millorar l\u2019estat de la pell, la simptomatologia, la dosi de medicaci\u00f3 i aportar una millor qualitat de vida als pacients afectats. Aquest va ser l\u2019objectiu de la confer\u00e8ncia que el Col\u00b7legi va [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2013-06-07T11:25:47+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"L\u2019atenci\u00f3 dermofarmac\u00e8utica en Psoriasi","datePublished":"2013-06-07T11:25:47+00:00","dateModified":"2013-06-07T11:25:47+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/"},"wordCount":115,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 farmac\u00e8utica","Formaci\u00f3"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/","url":"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/","name":"L\u2019atenci\u00f3 dermofarmac\u00e8utica en Psoriasi - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#primaryimage"},"thumbnailUrl":"","datePublished":"2013-06-07T11:25:47+00:00","dateModified":"2013-06-07T11:25:47+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2013\/06\/07\/latencio-dermofarmaceutica-en-psoriasi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"L\u2019atenci\u00f3 dermofarmac\u00e8utica en Psoriasi"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Tenir una visi\u00f3 integral de la psoriasi incidint en la dermocosm\u00e8tica i els nous productes sanitaris espec\u00edfics per millorar l\u2019estat de la pell, la simptomatologia, la dosi de medicaci\u00f3 i aportar una millor qualitat de vida als pacients afectats. Aquest va ser l\u2019objectiu de la confer\u00e8ncia que el Col\u00b7legi va [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/1851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=1851"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/1851\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=1851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=1851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=1851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}